首页|期刊导航|中国实验方剂学杂志|基于Wnt/β-catenin信号通路探讨小金丸含药血清抑制乳腺癌细胞的作用机制

基于Wnt/β-catenin信号通路探讨小金丸含药血清抑制乳腺癌细胞的作用机制OA

Exploring Mechanism of Xiaojinwan-containing Serum in Inhibiting Breast Cancer Cells Based on Wnt/β-catenin Signaling Pathway

中文摘要英文摘要

目的:探讨Wnt/β-连环蛋白(β-catenin)信号通路在小金丸含药血清干预人乳腺癌细胞MDA-MB-231上皮间质转化(EMT)过程中的作用及其相关机制.方法:以4 g·kg-1 小金丸灌胃SD大鼠制备含药血清.体外培养MDA-MB-231细胞.构建β-catenin过表达质粒和β-catenin干扰表达质粒转染至MDA-MB-231,采用前期研究效果最优的4 g·kg-1含药血清进行干扰和过表达β-catenin实验.干扰/过表达实验分组:干扰/过表达空白组、干扰/过表达β-catenin组、干扰/过表达空白+药物组、干扰/过表达 β-catenin+药物组.在显微镜下观察各组细胞形态,流式细胞术检测并记录各组细胞凋亡率,蛋白免疫印记法(Western blot)检测乳腺癌细胞的凋亡相关蛋白 B 细胞淋巴瘤-2(Bcl-2)及其相关 X 蛋白(Bax)、活性胱天蛋白酶-3(active Caspase-3)水平和EMT相关蛋白上皮钙黏蛋白(E-cadherin)、神经钙黏蛋白(N-cadherin)、波形蛋白(Vimentin)水平,实时荧光定量聚合酶链式反应(Real-time PCR)检测各组β-catenin mRNA表达.结果:干扰实验组结果显示,与干扰空白组比较,干扰β-catenin 组和干扰空白+药物组凋亡率明显升高(P<0.05,P<0.01);Bax、active Caspase-3、E-cadherin 的蛋白水平明显增高(P<0.05,P<0.01);Bcl-2、Vimentin的蛋白水平明显降低(P<0.05,P<0.01);干扰β-catenin组β-catenin mRNA表达明显降低(P<0.05),表达量为0.63±0.15,干扰空白+药物组β-catenin mRNA表达明显降低(P<0.05),表达量为0.79±0.33.与干扰β-catenin组比较,干扰 β-catenin+药物组的凋亡率显著升高(P<0.01);Bax、Caspase-3的蛋白水平明显增高(P<0.05,P<0.01);Bcl-2、N-cadherin、Vimentin的蛋白水平明显下降(P<0.05);干扰β-catenin+药物组β-catenin mRNA表达显著降低(P<0.01),表达量为0.22±0.08.与干扰空白+药物组比较,干扰 β-catenin+药物组的凋亡率显著升高(P<0.01);Bax、active cleaved Caspase-3、E-cadherin 的蛋白水平明显增高(P<0.05,P<0.01);Bcl-2、N-cadherin、Vimentin 的蛋白水平明显下降(P<0.05,P<0.01);β-catenin mRNA表达明显降低(P<0.05).过表达实验组中,与过表达空白组比较,过表达β-catenin组的凋亡率显著降低(P<0.01),过表达空白+药物组的凋亡率明显升高(P<0.05);过表达β-catenin组、过表达β-catenin+药物组中Bax、E-cadherin蛋白水平明显降低(P<0.05,P<0.01);Bcl-2、N-cadherin、Vimentin蛋白水平明显升高(P<0.05),过表达空白+药物组中Bax、E-cadherin蛋白水平明显升高(P<0.05,P<0.01);Bcl-2、N-cadherin、Vimentin 蛋白水平明显降低(P<0.05,P<0.01);过表达 β-catenin 组的β-catenin mRNA表达显著升高(P<0.01),表达量为7.26±1.03,过表达空白+药物组的β-catenin mRNA表达明显降低(P<0.05),表达量为0.73±0.14.与过表达β-catenin组比较,过表达β-catenin+药物组的凋亡率显著升高(P<0.01);Bax、E-cadherin蛋白水平明显升高(P<0.05);N-cadherin、Vimentin蛋白水平明显下降(P<0.05);过表达 β-catenin组+药物组的 mRNA 表达明显降低(P<0.05),表达量为4.65±1.02.与过表达空白+药物组比较,过表达β-catenin+药物组的凋亡率显著降低(P<0.01);Bax、E-cadherin蛋白水平显著降低(P<0.01);Bcl-2、N-cadherin、Vimentin蛋白水平明显升高(P<0.05);过表达β-catenin+药物组mRNA表达显著增高(P<0.01).结论:小金丸含药血清抑制乳腺癌细胞的增殖与其抑制EMT,与调控Wnt/β-catenin通路有关.

Objective:To investigate the role and underlying mechanism of the Wnt/β-catenin signaling pathway in the process of Xiaojinwan(XJW)-containing serum interfering with endothelial-mesenchymal transition(EMT)in human breast cancer MDA-MB-231 cells.Methods:XJW-containing serum was prepared by intragastric administration of XJW(4 g·kg-1)to SD rats.MDA-MB-231 cells were cultured in vitro.β-Catenin overexpression and knockdown plasmids were constructed and transfected into MDA-MB-231 cells.The optimal XJW-containing serum(4 g·kg-1)according to previous studies was used for β-catenin intervention and overexpression experiments.The groups for intervention/overexpression experiments included intervention/overexpression blank group,β-catenin intervention/overexpression group,intervention/overexpression blank+XJW group,and β-catenin intervention/overexpression+XJW group.Cell morphology was observed under a microscope.Flow cytometry was used to detect and record apoptosis rates.Western blot was performed to measure apoptosis-related proteins[B-cell lymphoma 2(Bcl-2),Bcl-2-associated X protein(Bax),and active-Caspase-3]and EMT-related proteins(E-cadherin,N-cadherin,and vimentin).Real-time polymerase chain reaction(Real-time PCR)was used to detect β-catenin mRNA expression levels in different groups.Results:Intervention experiment results showed that compared with the intervention blank group,the β-catenin intervention group and the intervention blank+XJW group showed increased apoptosis rates(P<0.05,P<0.01),elevated protein levels of Bax,active Caspase-3,and E-cadherin(P<0.05,P<0.01),and decreased protein levels of Bcl-2 and Vimentin(P<0.05,P<0.01).β-catenin mRNA expression was reduced in the β-catenin intervention group(P<0.05,0.63±0.15)and the intervention blank+XJW group(P<0.05,0.79±0.33).Compared with the β-catenin intervention group,the β-catenin intervention+XJW group exhibited an increased apoptosis rate(P<0.01),elevated Bax and active Caspase-3 protein levels(P<0.05,P<0.01),and decreased Bcl-2,N-cadherin,and Vimentin protein levels(P<0.05).β-catenin mRNA expression was further reduced in the β-catenin intervention+XJW group(P<0.01,0.22±0.08).Compared with the intervention blank+XJW group,the β-catenin intervention+XJW group showed an increased apoptosis rate(P<0.01),elevated Bax,active Caspase-3,and E-cadherin protein levels(P<0.05,P<0.01),and decreased Bcl-2,N-cadherin,and vimentin protein levels(P<0.05,P<0.01).β-catenin mRNA expression was also reduced(P<0.05).Overexpression experiment results showed that compared with the overexpression blank group,the β-catenin overexpression group exhibited a reduced apoptosis rate(P<0.01),while the overexpression blank+XJW group showed an increased apoptosis rate(P<0.05).In the β-catenin overexpression and β-catenin overexpression+XJW groups,Bax and E-cadherin protein levels decreased(P<0.05,P<0.01),while Bcl-2,N-cadherin,and vimentin levels increased(P<0.05).In the overexpression blank+XJW group,Bax and E-cadherin levels increased(P<0.05,P<0.01),while Bcl-2,N-cadherin,and vimentin levels decreased(P<0.05,P<0.01).β-catenin mRNA expression increased in the β-catenin overexpression group(P<0.01,7.26±1.03)but decreased in the overexpression blank+XJW group(P<0.05,0.73±0.14).Compared with the β-catenin overexpression group,the β-catenin overexpression+XJW group showed an increased apoptosis rate(P<0.01),elevated Bax and E-cadherin levels(P<0.05),and decreased N-cadherin and vimentin levels(P<0.05).β-catenin mRNA expression was reduced(P<0.05,4.65±1.02).Compared with the overexpression blank+XJW group,the β-catenin overexpression+XJW group exhibited a reduced apoptosis rate(P<0.01),decreased Bax and E-cadherin levels(P<0.01),and increased Bcl-2,N-cadherin,and Vimentin levels(P<0.05).β-catenin mRNA expression increased(P<0.01).Conclusion:XJW-containing serum inhibits breast cancer cell proliferation by suppressing EMT,which is associated with the regulation of the Wnt/β-catenin pathway.

汤宏棣;孙颖;王志斌;李仝;朱映黎;金孝博;高辰;李红凯;李志明;姚璐;宋凤丽;康宁;王文雯

北京中医药大学 第三附属医院,北京 100029||北京中医药大学,北京 100029北京中医药大学 第三附属医院,北京 100029北京同仁堂股份有限公司科学研究所,北京 100079北京中医药大学 第三附属医院,北京 100029北京中医药大学,北京 100029北京同仁堂股份有限公司科学研究所,北京 100079北京中医药大学 第三附属医院,北京 100029北京同仁堂股份有限公司科学研究所,北京 100079北京中医药大学 第三附属医院,北京 100029北京同仁堂股份有限公司科学研究所,北京 100079北京中医药大学 第三附属医院,北京 100029北京中医药大学 第三附属医院,北京 100029北京中医药大学 第三附属医院,北京 100029

医药卫生

小金丸含药血清MDA-MB-231细胞上皮间质转化(EMT)Wnt/β-连环蛋白(β-catenin)信号通路作用机制

Xiaojinwan-containing serumMDA-MB-231 cellsepithelial-mesenchymal transition(EMT)Wnt/β-catenin signaling pathwaymechanism

《中国实验方剂学杂志》 2026 (17)

13-22,10

国家自然科学基金面上项目(82474097)横向课题基金项目(HXGSHTBZYSY-2021031)河北省中医药管理局科研计划项目(B2025029)

10.13422/j.cnki.syfjx.20251421

评论